Research Portal
Schools
Publications
Researchers
Research Projects
Activities
Datasets
Staff login
Home
Researchers
Sridhar Chaganti
Sridhar Chaganti
Overview
Publications
Colleges, School and Institutes
Immunology and Immunotherapy
View graph of relations
Most downloaded publications
Greatly reduced risk of EBV reactivation in Rituximab-experienced recipients of Alemtuzumab-conditioned allogeneic HSCT
David Burns
,
Emma Martin
,
Andrew Bell
,
Paul Moss
,
Charles Craddock
,
Christopher Fox
&
Sridhar Chaganti
,
Jun 2016
,
In:
Bone Marrow Transplantation.
51
,
6
,
p. 825-832
Research output
:
Contribution to journal
›
Article
›
peer-review
164
downloads
Recent publications
Greatly reduced risk of EBV reactivation in Rituximab-experienced recipients of Alemtuzumab-conditioned allogeneic HSCT
David Burns
,
Emma Martin
,
Andrew Bell
,
Paul Moss
,
Charles Craddock
,
Christopher Fox
&
Sridhar Chaganti
,
Jun 2016
,
In:
Bone Marrow Transplantation.
51
,
6
,
p. 825-832
Research output
:
Contribution to journal
›
Article
›
peer-review
Memory B cell reconstitution following allogeneic haematopoietic stem cell transplantation is an EBV-associated transformation event
David Burns
,
Rosemary Tierney
,
Claire Shannon-Lowe
,
Charlotte Inman
,
Christopher Fox
,
Sridhar Chaganti
,
Charles Craddock
,
Paul Moss
,
Alan Rickinson
,
Martin Rowe
&
Andrew Bell
,
17 Dec 2015
,
In:
Blood.
126
,
25
,
p. 2665-2675
11 p.
Research output
:
Contribution to journal
›
Article
›
peer-review
Transfusion in CMV seronegative T -depleted allogeneic stem cell transplant recipients with CMV -unselected blood components results in zero CMV transmissions in the era of universal lekocyte reduction: a U.K dual centre experience.
Charles Craddock
&
Sridhar Chaganti
,
2015
,
In:
Transfusion Medicine.
Research output
:
Contribution to journal
›
Article
›
peer-review
View all (10)